November 7, 2021:

This month, the Big Ten Cancer Research Consortium features our member institution University of Iowa Holden Comprehensive Cancer Center and medical oncologist Margaret Byrne, MD, MS, clinical assistant professor of Internal Medicine-Hematology, Oncology, and Blood and Marrow Transplantation at the Carver College of Medicine.

Dr. Byrne’s research interests include early-phase clinical trials of adjunctive therapies to enhance the efficacy of immune checkpoint inhibitors in patients with head, neck, and lung cancers. Her clinical expertise includes thoracic malignancies and head and neck cancer. Read More

November 2, 2021:

Since its founding in 2013, the Big Ten Cancer Research Consortium (Big Ten CRC) has experienced steady growth, guided by a Steering Committee whose members consist of one representative from each institution. Collectively, the group meets regularly to oversee the activities of the consortium and to decide matters of policy. Each year, the committee appoints a chair and a vice-chair.

Peter G. Shields, MD (pictured left), of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) currently serves as Steering Committee chair, and Thomas G. Sors, PhD, of the Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D), is vice-chair, representing the Purdue University Center for Cancer Research.

Dr. Shields, a thoracic medical oncologist, oversees the scientific research programs and research infrastructure of the OSUCCC-James, which includes more than 330 cancer researchers and their teams from 11 of Ohio State’s 15 colleges. Through his experience, Dr. Shields understands the importance of multi-institution collaboration to meet the needs of cancer patients as well as investigators, many of whom are early in their careers. Read More